Aquablation Therapy introduced in Wales for the first time at Nuffield Health Cardiff and Vale Hospitals.
Nuffield Health Cardiff and Vale Hospitals is proud to announce the introduction of advanced robotic technology with the arrival of aquablation therapy, a minimally invasive, heat-free water-jet procedure designed to treat benign prostatic hyperplasia (BHP). On 31 January 2025 the first patients in Wales underwent this innovative treatment, marking a milestone in prostate care in the region.
BPH, a condition which affects up to 3 million men annually in the UK, is characterised by the enlargement of the prostate gland, which can narrow the urethra or press against the bladder. This often leads to symptoms such as difficulty urinating, frequent urination and incomplete bladder emptying. If left untreated, BPH may progress to more severe complications, such as acute urinary retention and infections.
Aquablation therapy, recommended by the National Institute of Care and Excellence (NICE,) offers a highly accurate and innovative solution to BPH. Clinical studies back its efficacy in relieving symptoms and its ability to maintain low rates of irreversible complications, regardless of prostate size or shape.
Melanie Webber Maybank, Hospital Director, explains,
“We’ve seen incredible results with MAKO robot- assisted surgery for joint replacements over the last three years. Now with Aquablation, we extend our advanced robotic arsenal to prostate surgery. Unlike traditional procedures, Aquablation uses heat-free water combined with ultrasound imaging and a camera to precisely target and remove excess prostate tissue. We are currently the only hospital in Wales able to offer this cutting- edge treatment.
This innovation represents our commitment to building a healthier nation and addressing health challenges with sustainable long term solutions. With 3 million men impacted by BPH annually in the UK- and 30,000 requiring surgery – this technology has the potential to change lives dramatically .”
Consultant Urological and Robotic Surgeon Mr Matthew Jeffries from Swansea University Medical School, who recently joined the consultant urology team at the Vale Hospital, says,
“I am delighted to be part of the Nuffield Health Urological team here and that we can offer men in South Wales a swift non- invasive service for the uncomfortable condition of BPH and so preserve continence, urine flow and erectile function. The enhanced imaging of Aquablation technology allows the surgeon to see the entire prostate in real time. Robotics combined with advanced computer software helps create a personalised treatment plan for me to precisely remove only the necessary excess tissue, using a robotically controlled jet of heat-free water. This technology offers our patients faster recovery times, fewer side effects and improved quality of life.”
Aquablation therapy consistently delivers patient-reported outcomes that meet or exceed alternative procedures. Data shows:
99.5% continence preservation
100% preservation of erectile function
89% retention of ejaculatory function
After surgery, many patients report an immediate improvement, while others experience noticeable changes within two to four weeks. Most patients return to daily activities within days although strenuous activities, like heavy lifting and sexual activity should be paused for a few weeks. Patients undergoing Aquablation typically remain in hospital for one to two days for recovery, ensuring they receive the best possible care as they return to their routines.
FREE MEET THE EXPERT EVENING at Vale Hospital, Hensol Castle Park, CF72 8JX
Monday 24th March, 5.30pm - 7.30pm
For more information Nuffield Health are hosting a patient information evening on Aquablation. All are welcome to attend the free Meet the Expert Event with Mr Matthew Jefferies, on Prostate, BPH & Aquablation.
Book on Eventbrite or ring 01443 449 251 to secure your free place or an appointment.
